SUN PHARMACEUTICAL INDUSTRIES
Back to Balance Sheet
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹4,276 Cr | ₹4,567 Cr | ₹4,061 Cr | ₹3,647 Cr | ₹4,639 Cr |
What is the latest Contingent Liabilities ratio of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹4,276 Cr |
| Mar2024 | ₹4,567 Cr |
| Mar2023 | ₹4,061 Cr |
| Mar2022 | ₹3,647 Cr |
| Mar2021 | ₹4,639 Cr |
How is Contingent Liabilities of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹4,276 Cr | -6.38 | |
| Mar2024 | ₹4,567 Cr | 12.46 | |
| Mar2023 | ₹4,061 Cr | 11.36 | |
| Mar2022 | ₹3,647 Cr | -21.38 | |
| Mar2021 | ₹4,639 Cr | - | |
Compare Contingent Liabilities of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,487.7 Cr | -0.5% | -1.9% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,514.0 Cr | 1.8% | 1.3% | 10.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,044.0 Cr | 2% | 2.4% | 11.2% | Stock Analytics | |
| CIPLA | ₹121,574.0 Cr | -0.2% | -0.7% | 1.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,919.0 Cr | -1% | 2.5% | -4.4% | Stock Analytics | |
| MANKIND PHARMA | ₹90,491.0 Cr | 2.4% | -2.2% | -20.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | -0.5% |
-1.9% |
-3% |
| SENSEX | 0.7% |
0.5% |
9% |
You may also like the below Video Courses